| Price | 1,485.50on 18-03-2019 at 16:30:00 |
|---|---|
| Change | 5.50 0.37% |
| Buy | 1,483.50 |
| Sell | 1,482.50 |
| Buy / Sell SN. Shares | |
| Last Trade: | Buy 6,064 at 1,485.50p |
| Day's Volume: | 1,680,333 |
| Last Close: | 1,480.00p |
| Open: | 1,480.00p |
| ISIN: | GB0009223206 |
| Day's Range | 1,474.50p - 1,489.00p |
| 52wk Range: | 1,242.50p - 1,548.50p |
| Market Capitalisation: | £12,949m |
| VWAP: | 0.00p |
| Shares in Issue: | 876m |
Sector: Health Care Equipment & Services
Listed in: FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 Low Yield
Recent Trades History Smith & Nephew (SN.) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 6,064 | 1,485.50 | Ordinary Delayed publication | 17:14:32 - 18-Mar-19 |
| Sell* | 133 | 1,482.113 | Ordinary Delayed publication | 16:50:43 - 18-Mar-19 |
| Buy* | 1,082 | 1,483.409 | 16:48:14 - 18-Mar-19 | |
| Sell* | 310 | 1,481.80 | 18:28:12 - 18-Mar-19 | |
| Sell* | 246 | 1,478.207 | 18:28:12 - 18-Mar-19 | |
| Sell* | 2,328 | 1,480.065 | 17:39:04 - 18-Mar-19 | |
| Buy* | 5,857 | 1,483.859 | 17:31:49 - 18-Mar-19 | |
| Sell* | 518 | 1,480.595 | 17:31:22 - 18-Mar-19 | |
| Sell* | 890 | 1,478.639 | 17:31:04 - 18-Mar-19 | |
| Buy* | 7,356 | 1,485.50 | 17:26:43 - 18-Mar-19 | |
Share Price History for Smith & Nephew |
|||||
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 18th Mar 2019 (Mon) | 1,480.00 | 1,489.00 | 1,474.50 | 1,480.00 | 1,680,333 |
| 15th Mar 2019 (Fri) | 1,478.00 | 1,485.50 | 1,473.00 | 1,470.50 | 3,648,999 |
| 14th Mar 2019 (Thu) | 1,468.00 | 1,475.50 | 1,459.50 | 1,474.00 | 1,749,217 |
| 13th Mar 2019 (Wed) | 1,468.50 | 1,476.50 | 1,466.50 | 1,479.00 | 2,278,159 |
| 12th Mar 2019 (Tue) | 1,460.50 | 1,485.00 | 1,450.50 | 1,462.00 | 3,185,032 |
| 11th Mar 2019 (Mon) | 1,463.50 | 1,485.00 | 1,458.50 | 1,455.00 | 1,669,263 |
| 8th Mar 2019 (Fri) | 1,452.50 | 1,461.00 | 1,448.50 | 1,458.50 | 1,206,160 |
| 7th Mar 2019 (Thu) | 1,452.50 | 1,460.50 | 1,446.50 | 1,462.50 | 1,742,574 |
| 6th Mar 2019 (Wed) | 1,465.50 | 1,472.50 | 1,454.00 | 1,465.50 | 1,371,572 |
| 5th Mar 2019 (Tue) | 1,440.50 | 1,470.00 | 1,440.00 | 1,448.50 | 1,503,392 |
| 4th Mar 2019 (Mon) | 1,454.50 | 1,459.50 | 1,445.50 | 1,439.00 | 1,521,183 |
| 1st Mar 2019 (Fri) | 1,443.50 | 1,453.50 | 1,438.00 | 1,436.50 | 1,764,403 |
| 28th Feb 2019 (Thu) | 1,427.50 | 1,437.50 | 1,417.00 | 1,427.00 | 4,162,471 |
| 27th Feb 2019 (Wed) | 1,427.00 | 1,429.00 | 1,419.50 | 1,424.50 | 2,272,704 |
| 26th Feb 2019 (Tue) | 1,434.00 | 1,434.00 | 1,419.50 | 1,441.50 | 1,688,108 |
| 25th Feb 2019 (Mon) | 1,436.00 | 1,448.00 | 1,436.00 | 1,433.50 | 3,711,382 |
| 22nd Feb 2019 (Fri) | 1,436.50 | 1,444.50 | 1,429.00 | 1,430.50 | 2,099,831 |
| 21st Feb 2019 (Thu) | 1,445.00 | 1,452.50 | 1,427.00 | 1,438.00 | 2,475,121 |
| 20th Feb 2019 (Wed) | 1,436.00 | 1,444.00 | 1,429.50 | 1,438.00 | 1,941,142 |
| 19th Feb 2019 (Tue) | 1,450.50 | 1,453.50 | 1,438.00 | 1,450.00 | 1,650,487 |
Smith & Nephew are presently the UK's largest medical technology company and one of global significance in its specialised field. Established over 150 years ago, the company now operates in over 30 countries worldwide, with their headquarters still being in London, UK. Their main focus revolves around developing and promoting novel products to help physicians treat aging patients with endoscopy techniques, orthopaedic reconstruction, trauma and advanced wound management being at the forefront of their research. The company feel that the increasingly aging population equals a significant growth potential for the already established markets of orthopaedics, endoscopy and wound management around the world.
Today, Smith & Nephew have over 1000 products in their arsenal and generate worldwide sales of over 3.4 billion dollars. They further report that over the last 5 years their revenues have grown from around nineteen hundred million dollars to over thirty three hundred million dollars – a percentage increase of nearly 100%. This success has been helped along by the launch of a new range of ingenious wound dressing products in 2008 and the acquisition of the Swiss company Plus Orthopaedics Holdings AG in 2007. Smith & Nephew research, develop and manufacture a number of new orthopaedic and wound management products each year, many of which quickly become established products within the UK and the US. The share price of this major medtech company has stayed stable for a number of years and continues to rise as new products are launched.
News - Sunday, July 20, 2014
The FTSE 100 has gotten off to a slow start this year, but Chris Burvill, manager of the Henderson Cautious Managed Fund, believes that the index could hit unprecedented highs in the second half of this year, potentially breaking the 7,500 barrier....
News - Friday, May 23, 2014
The FTSE 100 fell slightly on Thursday, following mixed economic signals from China, France and the USA. The UK’s leading index closed down b 0.48 points, at 6,820.56, as mining shares boosted the index during a see-saw trading day....
